Skip to main
IEX
IEX logo

IDEX (IEX) Stock Forecast & Price Target

IDEX (IEX) Analyst Ratings

Based on 22 analyst ratings
Buy
Strong Buy 36%
Buy 27%
Hold 36%
Sell 0%
Strong Sell 0%

Bulls say

IDEX's diverse portfolio across three segments – fluid and metering technologies, health and science technologies, and fire and safety and diversified products – positions it favorably for future growth, particularly with health and science technologies expected to demonstrate the highest organic growth at around 3%. Notably, the firm reported organic sales growth across its segments, with FSDP rising 8% and HST increasing 8%, driven by tailwinds in life sciences and other key markets such as pharmaceuticals and energy. Furthermore, with a revenue generation of $3.3 billion in 2024 and ongoing investments in innovation and growth-friendly acquisitions, IDEX is poised to leverage its strong market demand to enhance long-term performance.

Bears say

IDEX's recent financial reports indicate a troubling trend, with revenue growth lagging behind peers during the 2016-2018 period due to the shutdown of underperforming businesses. For 2025, the company is projecting cash earnings per share (EPS) in a downside scenario that could drastically fall to approximately $6.52 to $6.88, reflecting anticipated organic revenue declines and pressure on operating margins. Furthermore, the first quarter of 2025 guidance has been notably weak, with expectations of a 4% to 3% decline in organic sales, along with a 19% miss relative to consensus, driven by stock compensation impacts and non-recurring revenues from previous projects.

IDEX (IEX) has been analyzed by 22 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 27% recommend Buy, 36% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IDEX and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IDEX (IEX) Forecast

Analysts have given IDEX (IEX) a Buy based on their latest research and market trends.

According to 22 analysts, IDEX (IEX) has a Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $186.23, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $186.23, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IDEX (IEX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.